PHOT · As filed with the SEC
Growlife cash flow statement, by fiscal year
The statement as Growlife presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 | FY2017 Year ended Dec 31, 2017 | FY2016 Year ended Dec 31, 2016 | FY2015 Year ended Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Profit or Loss | (4,482,877) | — | — | — | (11,473,137) | (5,320,974) | (7,694,684) | (5,688,845) |
| (Income) Loss from discontinued operations | 1,931,250 | — | — | — | — | — | — | — |
| Gain on discontinued operations | (1,713,105) | — | — | — | — | — | — | — |
| Net loss from continuing operations | (4,264,732) | — | — | — | — | — | — | — |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation Expense | — | 37,152 | 37,152 | 89,322 | 80,125 | 1,890 | 8,437 | 13,715 |
| Restructuring Expense | — | — | 0 | 555,895 | — | — | — | — |
| Amortization Of Intangible Assets | — | 671,716 | 671,716 | 838,262 | 142,628 | 0 | 106,548 | 106,548 |
| Change in inventory reserve | — | — | — | — | — | — | — | 0 |
| Stock-Based Compensation Expense | — | — | 125,169 | 158,042 | 241,433 | 216,543 | 145,729 | 175,661 |
| Preferred shares issued for services | — | — | — | — | — | — | 0 | 300,000 |
| Interest Expense | — | 643,680 | 1,061,852 | 933,265 | 769,237 | 419,666 | 514,668 | (158,237) |
| Change in fair value of derivative liability | — | — | (199,479) | (494,558) | (977,732) | (496,306) | 1,324,384 | (723,740) |
| Expense related to warrant | — | — | — | — | — | — | — | 0 |
| Interest Expense | — | — | — | — | 421,666 | 203,697 | 120,824 | 310,500 |
| Loss on class action lawsuit settlements | — | — | — | — | — | — | 0 | 2,000,000 |
| Proceeds from Stock Issuance | — | — | — | — | — | — | 0 | 1,500,000 |
| Write-off of patent expenses | — | — | — | — | — | — | 0 | 3,600 |
| Excess and obsolete inventory | — | — | — | — | — | — | 0 | 20,215 |
| Realized gain on sale of investment | — | — | — | — | — | — | — | 0 |
| Loss on debt conversions | — | — | 945,169 | 1,767,325 | 6,519,467 | 2,502,819 | 2,889,540 | — |
| Restructuring Expense | — | — | — | 0 | 61,902 | 0 | 876,056 | — |
| Write-off of derivative liability to additional paid in capital | — | — | — | — | 0 | 537,698 | — | — |
| Loss on debt settlement | — | — | 2,422,500 | — | — | — | — | — |
| Stock-Based Compensation Expense | 0 | 15,476 | — | — | — | — | — | — |
| Net Cash from Operating Activities | — | 24,000 | 11,800 | 312,435 | 218,206 | 76,000 | 285,200 | 210,985 |
| Non-Interest Expense | 1,882,488 | 772,256 | — | — | — | — | — | — |
| Loss On Debt Conversion | — | 931,494 | — | — | — | — | — | — |
| Loss on cashless warrant conversion | 0 | 37,460 | — | — | — | — | — | — |
| Loss On Debt Settlement | — | 0 | — | — | — | — | — | — |
| (Gain) Loss on debt conversion | (204,868) | — | — | — | — | — | — | — |
| Change in fair value of derivative | 1,347,845 | 973,101 | — | — | — | — | — | — |
| (Gain) on forgiveness of debt | (183,449) | (206,287) | — | — | — | — | — | — |
| Gain on settlement of accounts payable | 0 | (1,025,400) | — | — | — | — | — | — |
| Fair value of derivatives expensed upon issuance | — | 1,429,138 | — | — | — | — | — | — |
| Accounts Receivable | — | 593,733 | (858,716) | (59,552) | 42,254 | — | — | 0 |
| Inventory | — | (729,036) | 30,150 | 191,990 | (326,986) | (47,225) | 20,014 | 464,696 |
| Prepaids costs | — | — | 0 | 3,418 | (3,418) | — | 0 | 41,791 |
| Other receivable | — | — | — | — | — | — | — | 0 |
| Other Assets | — | (161,000) | — | — | — | — | — | — |
| Deposits | — | 0 | 0 | 32,921 | (27,608) | 13,145 | (5,591) | 16,830 |
| Right of use, net | — | — | 11,409 | 13,984 | — | — | — | — |
| Right Of Use, Net | — | (5,422) | — | — | — | — | — | — |
| Change in Accounts Payable | — | 149 | 28,105 | 371,270 | 232,973 | (170,934) | 196,379 | 215,362 |
| Fair value of derivatives expensed upon conversion | 0 | — | — | — | — | — | — | — |
| Restricted Cash | — | — | — | — | — | — | — | 0 |
| Accounts payable | 38,605 | — | — | — | — | — | — | — |
| Accrued expenses | 38,303 | 40,764 | (83,433) | (131,331) | 116,625 | 19,503 | (22,791) | (209,972) |
| Change in Deferred Revenue | — | — | 0 | (89,504) | 79,504 | (37,995) | 22,995 | 25,000 |
| Deferred tax liability | — | — | (117,551) | (117,550) | — | — | — | — |
| Change in federal and state taxes payable | — | — | 343,125 | — | — | — | — | — |
| Change In Deferred Taxes | — | (246,649) | — | — | — | — | — | — |
| Change In Federal And State Taxes Payable | — | 213,827 | — | — | — | — | — | — |
| Net cash used in operating activities from continuing operations | (1,345,808) | — | — | — | — | — | — | — |
| Net Change in Cash | 30,310 | — | — | — | — | — | — | — |
| CASH USED BY OPERATING ACTIVITIES | (1,315,498) | (1,462,515) | (1,950,870) | (2,909,811) | (3,854,506) | (2,082,493) | (1,212,292) | (1,375,891) |
| Purchase Of Pp&e | — | (20,000) | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | 0 |
| Capital expenditures | — | — | — | — | — | — | — | 0 |
| Investment in purchased assets | — | — | 0 | (12,463) | (544,432) | (302,689) | — | — |
| Payment of advances | (160,000) | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | (11,190) | — | — | — | — | — | — | — |
| CASH USED IN INVESTING ACTIVITIES | (171,190) | (20,000) | 0 | (12,463) | (544,432) | (302,689) | 0 | 0 |
| Proceeds from the issuance of common stock rights | — | — | — | — | 2,533,125 | — | — | — |
| Warrant Exercise | — | 0 | — | — | — | — | — | — |
| Proceeds of convertible promissory note | 1,254,305 | 1,728,873 | — | — | — | — | — | — |
| Principal note | 473,000 | 337,055 | 2,723,846 | 1,416,137 | — | — | — | — |
| Repayment on capital lease | — | — | 0 | (8,534) | — | — | — | — |
| Repayment of convertible notes | (110,150) | (553,550) | (431,151) | (778,872) | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | 0 | — | — | — | — |
| Proceeds from Stock Issuance | — | — | — | 0 | 6,000 | — | — | 0 |
| Proceeds from notes payable, net | — | — | — | — | 2,825,000 | 3,860,344 | 1,255,000 | — |
| Proceeds from Debt Issuance | — | — | — | — | — | — | 0 | 1,150,000 |
| Series B Convertible Preferred Stock | — | — | — | — | — | — | 0 | 15 |
| Repayment Of Notes | — | (49,144) | — | — | — | — | — | — |
| Stock Repurchases (Issuances) | — | 0 | 485 | 0 | 1,300,000 | — | — | — |
| Cash payoff to TCA Global Credit Master Fund, LP | — | — | — | — | 0 | (1,509,041) | — | — |
| Repayment of notes payable | (13,117) | — | — | — | — | — | — | — |
| Payments of notes payable - related party | — | — | — | — | — | — | — | 0 |
| Purchase of shares in reverse stock split | (10,168) | — | — | — | — | — | — | — |
| Net cash provided by financing activities from continuing operations | 1,593,870 | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | (19,249) | — | — | — | — | — | — | — |
| CASH PROVIDED BY FINANCING ACTIVITIES | 1,574,621 | 1,463,234 | 2,293,180 | 628,731 | 6,664,125 | 2,351,303 | 1,255,000 | 1,150,015 |
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | — | — | 342,310 | (2,293,543) | 2,265,187 | (33,879) | 42,708 | (225,876) |
| CASH AND CASH EQUIVALENTS, beginning of period | — | 383,144 | 40,834 | 2,334,377 | 69,191 | 103,070 | 60,362 | 286,238 |
| CASH AND CASH EQUIVALENTS, end of period | — | — | 383,144 | 40,834 | 2,334,377 | 69,191 | 103,070 | 60,362 |
| Interest Expense | — | — | — | — | 0 | 0 | 0 | 10,500 |
| Cash paid for income taxes | — | — | — | — | 0 | 0 | 0 | 0 |
| Net Change In Cash And Cash Equivalents | — | (19,281) | — | — | — | — | — | — |
| Cash And Cash Equivalents, Beginning Of Period | 363,863 | 383,144 | — | — | — | — | — | — |
| Cash And Cash Equivalents, End Of Period | — | 363,863 | — | — | — | — | — | — |
| NET CHANGE IN CASH AND CASH EQUIVALENTS | 87,933 | — | — | — | — | — | — | — |
| CASH AND CASH EQUIVALENTS, beginning of period | 6,275 | — | — | — | — | — | — | — |
| CASH AND CASH EQUIVALENTS, end of period | 94,208 | — | — | — | — | — | — | — |
| Six percent Senior secured convertible notes converted into common stock | — | — | — | — | — | — | — | 0 |
| Seven percent Senior secured convertible notes converted into common stock | — | — | — | — | — | — | — | 0 |
| Twelve percent Senior secured convertible notes converted into common stock | — | — | — | — | — | — | — | 0 |
| Common stock issued for cashless exercise of options | — | — | — | — | — | — | — | 0 |
| Shares issued for convertible note and interest conversion | — | — | 1,947,819 | 1,834,246 | 3,338,082 | 2,329,800 | 2,764,406 | — |
| Shares issued for debt conversion | — | — | — | — | — | 0 | — | — |
| Shares issued for class action settlements | — | — | — | — | — | 0 | 2,000,000 | — |
| Shares issued for mezzanine equity | — | — | — | — | — | 0 | 300,000 | — |
| Series B Convertible Preferred Stock converted into convertible notes payable | — | — | — | — | — | 0 | (1,500,000) | — |
| Series B Convertible Preferred Stock converted into convertible notes payable debt discount | — | — | — | — | — | 0 | 315,669 | — |
| Common stock issued for conversion of accounts payable | — | — | — | — | 33,000 | 548,539 | 144,000 | 171,000 |
| Acquisition of EZ-Clone Erterprises, Inc.- intangible assets | — | — | — | — | 3,423,081 | — | — | — |
| Acquisition of EZ-Clone Erterprises, Inc. | — | — | — | — | 1,395,000 | — | — | — |
| Noncontrolling interest in EZ-Clone Enterprises, Inc. | — | — | — | — | 1,931,645 | — | — | — |
| Common shares issued for accounts payable | — | — | — | 0 | — | — | — | — |
| Issuance of stock for debt issuance costs | — | — | 586,565 | — | — | — | — | — |
| Loss of debt conversions - issuance of stock | — | — | 984,169 | 2,035,876 | — | — | — | — |
| Gain on debt conversions - reduction of accounts payable | — | — | 39,000 | 268,551 | — | — | — | — |
| Acquisition of EZ-Clone Enterprises, Inc. - intangible assets | — | — | — | 0 | — | — | — | — |
| Stock issued for acquisition of EZ-Clone Enterprises, Inc. | — | — | — | 0 | — | — | — | — |
| Issuance of noncontrolling interest for EZ Clone Acquistion | — | — | — | 0 | — | — | — | — |
| Conversion of noncontrolling interest to acquisition payable | — | — | 0 | 1,343,895 | — | — | — | — |
| Shares Issued For Convertible Note And Interest Conversion | — | 2,502,596 | — | — | — | — | — | — |
| Loss Of Debt Conversions- Issuance Of Stock | — | 0 | — | — | — | — | — | — |
| Gain On Debt Conversions- Reduction Of Accounts Payable | — | 0 | — | — | — | — | — | — |
| Shares Issued For Liability Settlement | — | 1,397,100 | — | — | — | — | — | — |
| Purchase of fixed asset for notes payable | — | 137,725 | — | — | — | — | — | — |
| Derivative liability settled in shares | — | 1,805,403 | — | — | — | — | — | — |
| Value of shares issued for convertible note conversion | 1,682,698 | — | — | — | — | — | — | — |
| Value of shares issued for liability settlement | 1,046,425 | — | — | — | — | — | — | — |
| Value of shares issued for loan commitment fees | 327,792 | — | — | — | — | — | — | — |
| Net Loss | — | (5,472,668) | (6,379,838) | (7,285,445) | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.